Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola E Dahl

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Drugs|December 14, 2004
Orthopaedic surgery as a model for drug development in thrombosisOla E Dahl
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 22, 2009
Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimenOla E Dahl
Thrombosis Research|October 3, 2012
Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardizationOla E Dahl
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 19, 2024
Ola E Dahl
Vascular Health and Risk Management|February 11, 2012
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disordersOla E Dahl
Current Opinion in Pulmonary Medicine|August 13, 2002
Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgeryOla E Dahl, David Bergqvist
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|April 25, 2015
The population attributable risk of nutrition and lifestyle on hip fracturesAre Hugo Pripp, Ola E Dahl
Clinical Orthopaedics and Related Research|February 4, 2020
Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture RegisterOla E Dahl, Are Hugo Pripp
Seminars in Vascular Medicine|August 27, 2005
Ximelagatran as a new oral anticoagulant for thrombosisOla E Dahl, Jan Jacques Michiels
Drugs|March 17, 2004
Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitorsBengt I Eriksson, Ola E Dahl
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Drugs|December 14, 2004
Orthopaedic surgery as a model for drug development in thrombosisOla E Dahl
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 22, 2009
Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimenOla E Dahl
Thrombosis Research|October 3, 2012
Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardizationOla E Dahl
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 19, 2024
Ola E Dahl
Vascular Health and Risk Management|February 11, 2012
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disordersOla E Dahl
Current Opinion in Pulmonary Medicine|August 13, 2002
Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgeryOla E Dahl, David Bergqvist
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|April 25, 2015
The population attributable risk of nutrition and lifestyle on hip fracturesAre Hugo Pripp, Ola E Dahl
Clinical Orthopaedics and Related Research|February 4, 2020
Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture RegisterOla E Dahl, Are Hugo Pripp
Seminars in Vascular Medicine|August 27, 2005
Ximelagatran as a new oral anticoagulant for thrombosisOla E Dahl, Jan Jacques Michiels
Drugs|March 17, 2004
Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitorsBengt I Eriksson, Ola E Dahl
Pageof 6